435 related articles for article (PubMed ID: 30686985)
1. Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges.
Pulgar VM
Front Neurosci; 2018; 12():1019. PubMed ID: 30686985
[TBL] [Abstract][Full Text] [Related]
2. Transcellular brain drug delivery: A review on recent advancements.
Azarmi M; Maleki H; Nikkam N; Malekinejad H
Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
[TBL] [Abstract][Full Text] [Related]
3. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
Choi ES; Shusta EV
Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619
[TBL] [Abstract][Full Text] [Related]
4. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
5. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
Tashima T
Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
[TBL] [Abstract][Full Text] [Related]
6. Overcoming blood-brain barrier transport: Advances in nanoparticle-based drug delivery strategies.
Ding S; Khan AI; Cai X; Song Y; Lyu Z; Du D; Dutta P; Lin Y
Mater Today (Kidlington); 2020; 37():112-125. PubMed ID: 33093794
[TBL] [Abstract][Full Text] [Related]
7. Receptor-mediated therapeutic transport across the blood-brain barrier.
Wang YY; Lui PC; Li JY
Immunotherapy; 2009 Nov; 1(6):983-93. PubMed ID: 20635914
[TBL] [Abstract][Full Text] [Related]
8. Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges.
Choi H; Choi K; Kim DH; Oh BK; Yim H; Jo S; Choi C
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336049
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive approaches for drug delivery to the brain based on the receptor mediated transport.
Fang F; Zou D; Wang W; Yin Y; Yin T; Hao S; Wang B; Wang G; Wang Y
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():1316-1327. PubMed ID: 28482500
[TBL] [Abstract][Full Text] [Related]
10. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated transcytosis of macromolecules across the blood-brain barrier.
Baghirov H
Expert Opin Drug Deliv; 2023; 20(12):1699-1711. PubMed ID: 37658673
[TBL] [Abstract][Full Text] [Related]
12. Application of the Phage Display Technology for the Development of Peptide- mediated Drug Delivery Systems through the Blood-Brain Barrier.
Suárez VM; Vispo NS; Ramos OS
Curr Pharm Biotechnol; 2021; 22(11):1394-1403. PubMed ID: 33397231
[TBL] [Abstract][Full Text] [Related]
13. A novel LRP1-binding peptide L57 that crosses the blood brain barrier.
Sakamoto K; Shinohara T; Adachi Y; Asami T; Ohtaki T
Biochem Biophys Rep; 2017 Dec; 12():135-139. PubMed ID: 29090274
[TBL] [Abstract][Full Text] [Related]
14. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
15. Engineering and pharmacology of blood-brain barrier-permeable bispecific antibodies.
Stanimirovic D; Kemmerich K; Haqqani AS; Farrington GK
Adv Pharmacol; 2014; 71():301-35. PubMed ID: 25307221
[TBL] [Abstract][Full Text] [Related]
16. From the Blood to the Central Nervous System: A Nanoparticle's Journey Through the Blood-Brain Barrier by Transcytosis.
Fullstone G; Nyberg S; Tian X; Battaglia G
Int Rev Neurobiol; 2016; 130():41-72. PubMed ID: 27678174
[TBL] [Abstract][Full Text] [Related]
17. Use of LDL receptor-targeting peptide vectors for
Molino Y; David M; Varini K; Jabès F; Gaudin N; Fortoul A; Bakloul K; Masse M; Bernard A; Drobecq L; Lécorché P; Temsamani J; Jacquot G; Khrestchatisky M
FASEB J; 2017 May; 31(5):1807-1827. PubMed ID: 28108572
[TBL] [Abstract][Full Text] [Related]
18. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
[TBL] [Abstract][Full Text] [Related]
19. Transcytosis at the blood-brain barrier.
Ayloo S; Gu C
Curr Opin Neurobiol; 2019 Aug; 57():32-38. PubMed ID: 30708291
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin as a new transporter of nanoparticles for receptor-mediated transcytosis in rat brain microvessels.
Kim SY; Choi ES; Lee HJ; Moon C; Kim E
Colloids Surf B Biointerfaces; 2015 Dec; 136():989-96. PubMed ID: 26562191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
